What are the clinical indications for using low-molecular-weight heparins, and how do they compare to other anticoagulants in specific conditions?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What are the clinical indications for using low-molecular-weight heparins, and how do they compare to other anticoagulants in specific conditions?
Low-molecular-weight heparins (LMWHs) are indicated for preventing and treating deep vein thrombosis and pulmonary embolism. They offer a more predictable response than unfractionated heparin and lower bleeding risk compared to warfarin.